99 related articles for article (PubMed ID: 8093155)
1. Resistance to murine acquired immunodeficiency syndrome (MAIDS).
Gilmore GL
Science; 1994 Jul; 265(5169):264. PubMed ID: 8093155
[No Abstract] [Full Text] [Related]
2. Resistance to murine acquired immunodeficiency syndrome (MAIDS).
Morawetz RA; Doherty TM; Giese NA; Hartley JW; Müller W; Kühn R; Rajewsky K; Coffman R; Morse HC
Science; 1994 Jul; 265(5169):264-6; author reply 267. PubMed ID: 8023146
[No Abstract] [Full Text] [Related]
3. Resistance of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS).
Kanagawa O; Vaupel BA; Gayama S; Koehler G; Kopf M
Science; 1993 Oct; 262(5131):240-2. PubMed ID: 8211142
[TBL] [Abstract][Full Text] [Related]
4. Anti-Gag cytolytic T lymphocytes specific for an alternative translational reading frame-derived epitope and resistance versus susceptibility to retrovirus-induced murine AIDS in F(1) mice.
Mayrand SM; Healy PA; Torbett BE; Green WR
Virology; 2000 Jul; 272(2):438-49. PubMed ID: 10873788
[TBL] [Abstract][Full Text] [Related]
5. Delayed progression of a murine retrovirus-induced acquired immunodeficiency syndrome in X-linked immunodeficient mice.
Hitoshi Y; Okada Y; Sonoda E; Tominaga A; Makino M; Suzuki K; Kinoshita J; Komuro K; Mizuochi T; Takatsu K
J Exp Med; 1993 Mar; 177(3):621-6. PubMed ID: 8382252
[TBL] [Abstract][Full Text] [Related]
6. Host resistance and susceptibility to MAIDS virus: a case of Th cell dichotomy.
Morelli L; Skamene E; Gervais F
Folia Biol (Praha); 1994; 40(5):249-62. PubMed ID: 7895855
[No Abstract] [Full Text] [Related]
7. Glycyrrhizin improves the resistance of MAIDS mice to opportunistic infection of Candida albicans through the modulation of MAIDS-associated type 2 T cell responses.
Utsunomiya T; Kobayashi M; Ito M; Pollard RB; Suzuki F
Clin Immunol; 2000 May; 95(2):145-55. PubMed ID: 10779408
[TBL] [Abstract][Full Text] [Related]
8. Does preferential Th subset activation contribute to the murine acquired immunodeficiency disease (MAIDS)?
Torbett BE; Mosier DE
Res Immunol; 1994; 145(8-9):696-701; discussion 701-2. PubMed ID: 7754222
[No Abstract] [Full Text] [Related]
9. Th0-like CD4+ T cells protect mice with murine retrovirus-induced immunodeficiency syndrome (MAIDS) against co-infection with Listeria monocytogenes.
Hiromatsu K; Nishimura H; Kimura K; Aoki Y; Usami J; Kobayashi N; Makino M; Yoshikai Y
Immunology; 1996 Dec; 89(4):532-8. PubMed ID: 9014817
[TBL] [Abstract][Full Text] [Related]
10. Murine cytomegalovirus downregulates interleukin-17 in mice with retrovirus-induced immunosuppression that are susceptible to experimental cytomegalovirus retinitis.
Blalock EL; Chien H; Dix RD
Cytokine; 2013 Mar; 61(3):862-75. PubMed ID: 23415673
[TBL] [Abstract][Full Text] [Related]
11. Retrovirus-elicited interleukin-12 and tumour necrosis factor-alpha as inducers of interferon-gamma-mediated pathology in mouse AIDS.
Giese NA; Gazzinelli RT; Actor JK; Morawetz RA; Sarzotti M; Morse HC
Immunology; 1996 Mar; 87(3):467-74. PubMed ID: 8778035
[TBL] [Abstract][Full Text] [Related]
12. Induction of murine acquired immunodeficiency syndrome (MAIDS) in allophenic mice generated from strains susceptible and resistant to disease.
Sechler JM; Lawler A; Hartley JW; Morse HC; McCarty TC; Swofford R; Rosenberg AS
J Exp Med; 1996 Dec; 184(6):2101-8. PubMed ID: 9005249
[TBL] [Abstract][Full Text] [Related]
13. T cell shift: key to AIDS therapy?
Cohen J
Science; 1993 Oct; 262(5131):175-6. PubMed ID: 8211135
[No Abstract] [Full Text] [Related]
14. Influence of H-2 class II antigens on the development of murine AIDS.
Makino M; Tang Y; Murphy DB; Fredrickson TN; Okada Y; Fujiwara M; Chattopadhyay SK; Mizuochi T; Komuro K; Morse HC
J Immunol; 1994 Apr; 152(8):4157-64. PubMed ID: 8144977
[TBL] [Abstract][Full Text] [Related]
15. Immune responses of IL-4, IL-5, IL-6 deficient mice.
Kopf M; Le Gros G; Coyle AJ; Kosco-Vilbois M; Brombacher F
Immunol Rev; 1995 Dec; 148():45-69. PubMed ID: 8825282
[No Abstract] [Full Text] [Related]
16. Murine AIDS, a key to understanding retrovirus-induced immunodeficiency.
Liang B; Wang JY; Watson RR
Viral Immunol; 1996; 9(4):225-39. PubMed ID: 8978019
[TBL] [Abstract][Full Text] [Related]
17. An IFN-gamma-dependent pathway plays a critical role in the pathogenesis of murine immunodeficiency syndrome induced by LP-BM5 murine leukemia virus.
Uehara S; Hitoshi Y; Numata F; Makino M; Howard M; Mizuochi T; Takatsu K
Int Immunol; 1994 Dec; 6(12):1937-47. PubMed ID: 7696211
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the CD154-positive and CD40-positive cellular subsets required for pathogenesis in retrovirus-induced murine immunodeficiency.
Green KA; Noelle RJ; Durell BG; Green WR
J Virol; 2001 Apr; 75(8):3581-9. PubMed ID: 11264347
[TBL] [Abstract][Full Text] [Related]
19. The autoimmune accelerating yaa mutation does not accelerate murine AIDS.
Hügin AW; Fossati-Jimack L; Izui S
Cell Immunol; 2000 Mar; 200(2):76-80. PubMed ID: 10753498
[TBL] [Abstract][Full Text] [Related]
20. Induction of CD4 T cell changes in murine AIDS is dependent on costimulation and involves a dysregulation of homeostasis.
Yen MH; Lepak N; Swain SL
J Immunol; 2002 Jul; 169(2):722-31. PubMed ID: 12097374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
